Tumour type | Tumour type | Specimen type |
Presence of associated epithelial dysplasia when identified | Assessment of minimum depth of invasion | Length of specimen |
Assessment of minimum depth of invasion, identification of submucosal invasion when this is present in the biopsy (level, not measurement) | Presence of associated epithelial dysplasia when identified | Site of tumour |
| Identification of submucosal invasion when present | Macroscopic appearance of tumour |
| Assessment of completeness of excision of both dysplastic and malignant components | Dimensions of tumour |
| Assessment of vascular invasion | Distance to margins |
| | Invasive tumour type |
| | Invasive tumour grade of differentiation |
| | Character of the invasive margin that is expansile or infiltrative gastric cancer |
| | Serosal involvement |
| | Depth of invasion |
| | Vascular invasion |
| | Number of regional lymph nodes examined |
| | Number of involved regional lymph nodes |
| | Number and site(s) of distant (non-regional) lymph nodes submitted and number involved (M1) |
| | Distance to circumferential margin and status of this margin (in oesophageal cancer <1 mm regarded as involved). Local dissection of lymph nodes may compromise the estimation of the circumferential margin, but the distance to the remaining margin should be stated |
| | Status of proximal and distal margins |
| | Other relevant pathology (Barrett's oesophagus, background dysplasia, chronic gastritis, Helicobacter pyloristatus, etc.) |
| | TMN staging system, including R status |
| | Response to neoadjuvant therapy categorised with the Mandard criteria68 |